Skip to main content
Viewing from: Department GEZ-LTA Erasmushogeschool
Intended for healthcare professionals

BMJ Journals

  • Log In More
    Log in via Institution
    Log in via OpenAthens

    Log in using your username and password

    For personal accounts OR managers of institutional accounts
    Forgot your log in details?Register a new account?
    Forgot your user name or password?
  • Basket
  • Search More
    Advanced search
Journal for ImmunoTherapy of Cancer
  • Latest content
  • Browse by collection
  • Archive
  • Authors
  • About

Advanced search

  • Close More

    Main menu

    • Latest content
    • Browse by collection
    • Archive
    • Authors
    • About
  • Log in More
    Log in via Institution
    Log in via OpenAthens

    Log in using your username and password

    For personal accounts OR managers of institutional accounts
    Forgot your log in details?Register a new account?
    Forgot your user name or password?
  • BMJ Journals More
    You are viewing from: Department GEZ-LTA Erasmushogeschool

You are here

  • Home
  • Zoledronate
Email alerts

Zoledronate

  • Enhancing adoptive cancer immunotherapy with Vγ2Vδ2 T cells through pulse zoledronate stimulation
    Mohanad H. Nada, Hong Wang, Grefachew Workalemahu, Yoshimasa Tanaka, Craig T. Morita
    Journal for ImmunoTherapy of Cancer Dec 2017, 5 (1) 9; DOI: 10.1186/s40425-017-0209-6
  • Special collections
    • COVID-19 (46)
    • Editor's choice
    • JITC
      • Aging and diversity, equity, and inclusion (DEI) with regard to cancer immunotherapy and understudied populations
      • Aging and diversity, equity, and inclusion (DEI) with regard to cancer immunotherapy and understudied populations
      • Basic Tumor Immunology (620)
      • Cancer Immunotherapy in Understudied Populations (5)
      • Case Reports (192)
      • Clinical Trials Monitor (17)
      • Clinical/Translational Cancer Immunotherapy (1073)
      • Commentary/Editorials (190)
      • Computational I-O (6)
      • COVID-19 and Cancer Immunotherapy (10)
      • Emerging Immunotherapeutic Agents (5)
      • Guidelines and Consensus Statements (61)
      • Guidelines and Consensus Statements (52)
      • Imaging and Immunotherapy (9)
      • Immune Cell Therapies and Immune Cell Engineering (302)
      • Immune Checkpoints - Beyond PD-1 (8)
      • Immune Checkpoints Beyond PD-1 Series (8)
      • Immune Monitoring Technology Primers (12)
      • Immunotherapy Biomarkers (510)
      • Liquid Biopsies (8)
      • Microbial-Based Cancer Immunotherapy (4)
      • Oncolytic and Local Immunotherapy (172)
      • Reviews (262)
      • SITC 40th Anniversary: I-O Progress and Potential (7)
      • The Next Wave of Immuno-oncology: A Roadmap from the Society for Immunotherapy of Cancer (SITC) (1)
    • Open access (6905)
    • Press releases (6)
  • Society for Immunotherapy of Cancer
  • Content
    • Latest content
    • Browse by collection
    • Archive
  • Journal
    • About
    • Editorial board
    • Thank you to our reviewers
    • Sign up for email alerts
  • Authors
    • Instructions for authors
    • Submit an article
    • Open Access at BMJ
  • Help
    • Contact us
    • Reprints
    • Permissions
    • Advertising
    • Feedback form
  • RSS
  • Twitter
  • Website Terms & Conditions
  • Privacy & Cookies
  • Contact BMJ

Online ISSN: 2051-1426
Copyright © 2025 BMJ Publishing Group Ltd & Society for Immunotherapy of Cancer. All rights, including for text and data mining, AI training, and similar technologies, are reserved.